Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M, Heeboll S, Horwich A, Huddart R, Khoo V, Eeles R, Cooper C, Sydes M, Dearnaley D, Parker C. Vergis R, et al. Among authors: horwich a. Lancet Oncol. 2008 Apr;9(4):342-51. doi: 10.1016/S1470-2045(08)70076-7. Epub 2008 Mar 17. Lancet Oncol. 2008. PMID: 18343725 Free article.
Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.
Vergis R, Corbishley CM, Thomas K, Horwich A, Huddart R, Khoo V, Eeles R, Sydes MR, Cooper CS, Dearnaley D, Parker C. Vergis R, et al. Among authors: horwich a. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):35-41. doi: 10.1016/j.ijrobp.2009.07.1728. Epub 2010 Jan 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 20092961 Clinical Trial.
Diethylstilbestrol in castration-resistant prostate cancer.
Wilkins A, Shahidi M, Parker C, Gunapala R, Thomas K, Huddart R, Horwich A, Dearnaley D. Wilkins A, et al. Among authors: horwich a. BJU Int. 2012 Dec;110(11 Pt B):E727-35. doi: 10.1111/j.1464-410X.2012.11546.x. Epub 2012 Oct 30. BJU Int. 2012. PMID: 23110500 Clinical Trial.
Medium-term outcomes of active surveillance for localised prostate cancer.
Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, Huddart RA, Dearnaley DP, Parker CC. Selvadurai ED, et al. Among authors: horwich a. Eur Urol. 2013 Dec;64(6):981-7. doi: 10.1016/j.eururo.2013.02.020. Epub 2013 Feb 18. Eur Urol. 2013. PMID: 23473579
Identification of new genetic risk factors for prostate cancer.
Guy M, Kote-Jarai Z, Giles GG, Al Olama AA, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL; UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jameson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF, Eeles RA. Guy M, et al. Among authors: horwich a. Asian J Androl. 2009 Jan;11(1):49-55. doi: 10.1038/aja.2008.18. Epub 2008 Dec 1. Asian J Androl. 2009. PMID: 19050691 Free PMC article. Review.
542 results